NCT06745492View on ClinicalTrials.gov

Low-dose Neostigmine at TOF Ratio of 0.7 Improves Neuromuscular Recovery

CompletedOBSERVATIONAL
Enrollment

59

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

August 20, 2023

Study Completion Date

August 25, 2023

Conditions
Recovery Time
Interventions
DRUG

Neostigmine + Glycopyrrolate

a 20 mcg/kg of neostigmine and 4 mcg/kg of glycopyrrolate were administered at a TOF ratio of 0.7.

Trial Locations (1)

Unknown

Seoul National University Bundang Hospital, Seongnam

All Listed Sponsors
lead

Seoul National University Hospital

OTHER